533 results
8-K
EX-10.1
1f5i2f 0vml
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.2
reppbw9dfd7
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-2.1
o87fzfmd qtn3uvfu
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-4.1
nc3d6d6nof7wmlk4vk3
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-3.1
djwqli
8 Apr 24
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-10.1
9lpo785l02
25 Jan 24
Entry into a Material Definitive Agreement
8:34am
8-K
nrchjdkjbkdhsigpnp
17 Jan 24
Entry into a Material Definitive Agreement
7:56am
8-K
EX-1.1
cpal8xenis7jvk3g
9 Nov 23
Windtree Therapeutics Reports Third Quarter 2023 Financial Results and Provides Key Business Updates
4:21pm
424B5
3vinv43wsfwp81dk0hv
9 Nov 23
Prospectus supplement for primary offering
4:11pm